paromomycin has been researched along with Empyema in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kohno, S; Morinaga, Y; Nagaoka, K; Yanagihara, K | 1 |
| Ando, Y; Kondo, H; Miwa, T; Suhachiro, M; Yokouchi, S | 1 |
2 other study(ies) available for paromomycin and Empyema
| Article | Year |
|---|---|
Detection of Fusobacterium nucleatum in two cases of empyema and lung abscess using paromomycin-vancomycin supplemented Brucella HK agar.
Topics: Agar; Anti-Bacterial Agents; Bacteriological Techniques; Brucella; Culture Media; Empyema; Fusobacterium Infections; Fusobacterium nucleatum; Humans; Lung Abscess; Male; Middle Aged; Paromomycin; Sequence Analysis, DNA; Vancomycin | 2017 |
[Clinical experiences of lividomycin on respiratory tract infections (author's transl)].
Topics: Acute Disease; Adult; Aged; Bronchiectasis; Bronchitis; Drug Resistance, Microbial; Empyema; Female; Haemophilus; Humans; Male; Middle Aged; Neisseria; Paromomycin; Pneumonia; Respiratory Tract Infections; Staphylococcus; Streptococcus | 1975 |